$NVDA 20250110 136.0 PUT$ Really short dated CSPut on NVDA. Trying to acquire the underlying at this point as the recent event has shown some big muscles Lining up going into 2025. Believe NVDA will thrive in coming earnings and beyond. $NVDA 20250110 136.0 PUT$
$MSTR 20250110 400.0 CALL$ MSTR: took opportunity to sell naked call on MSTR as BTC and general market is more bearish and on the way down today. Short term trade and will expire this Friday 10th Jan.
$Serve Robotics Inc.(SERV)$ Seeing potential in the robotics area and therefore making a small entry to test the waters to then to assess a decision later to see feasibility of a larger investment.
Since January 9 is a special "closed day" this year, there are some arbitrage opportunities.On January 8, there were some arbitrage opportunities in the $Invesco QQQ(QQQ)$ expiration dates of January 8 and January 9 for two at-the-money (ATM) options (mainly focused on the 515 strike).Because of the January 9 vacation, the options expiring on January 9 will settle at the January 8 closing price, and the theoretical value of the two options as calculated by the BSM model should be the same.However, a spread occurs.Therefore, if one buys 1.8 of the 515's PUT and sells 1.9 of the 515's PUT at the same time, one can easily eat the Premium.As an analogy, at the close of trading on January 6, QQQ's 515's PUT for January 8 expiration averaged $0.61, while
$ACN VERTICAL 250214 PUT 340.0/PUT 335.0$ In the daily chart, the price looks to have reach its bottom at $345 and moving up. So, I have decided to open this bull put spread, with short call at $340, a $5 safety margin from the support level of $345.
Medical Value Stocks MRNA and PFE will Shine in 5 Years
Although high-valuation stocks in the current U.S. stock market continue to rise, and value stocks have lagged far behind growth stocks in recent years, stock valuations are still crucial for investors. Specifically in the medical sector, although the performance of U.S. medical stocks in the past two years has not been outstanding, the valuation is also lower than the $.SPX(.SPX)$ index. As market expectations for the medical sector improve, the industry will also regain the favor of value investors.Looking ahead to the next five years, the following two U.S. medical value stocks are expected to shine.U.S. medical value stocks 1: $Moderna, Inc.(MRNA)$ Moderna has become a household name for developing an
🎯 [Daily Poll] Jensen Huang: Quantum Computing Still Decades Away
Quantum computing stocks, once hailed as the next AI-driven boom, hit a wall after Nvidia CEO Jensen Huang’s remarks at Analyst Day.r/wallstreetbetsHuang tempered expectations, stating quantum computing is best for small data and complex computations but struggles with large datasets. He projected “very useful” quantum computers could be 20 years away, aligning with Boston Consulting Group’s prediction of full-scale fault tolerance only post-2040.Stocks like $IONQ Inc.(IONQ)$, $Rigetti Computing(RGTI)$, $D-Wave Quantum Inc.(QBTS)$ tumbled, with losses between 30-50%.Is the quantum hype ahead of its time?[Doubt]
$PLTR 20250117 69.0 PUT$ Selling a Short-Dated PLTR $69 Put – A Quick Premium Play! 💰 I sold a PLTR put with a $69 strike price that expires in the next 10 days, collecting a $1.56 premium. This short-term trade allows me to take advantage of time decay while betting that PLTR stays above $69. My View on PLTR’s Support 📉 I believe $69 is a strong support level, so if PLTR holds or rises, my put option will expire worthless, and I’ll keep the full premium. If PLTR moves up quickly, I could buy back the put at a lower price to lock in an early profit. If PLTR drops below $69, I might get assigned, but with the premium factored in, my effective cost basis will be $67.44 ($69 - $1.56), which I find reasonable for a potential r
$GME 20250117 37.5 CALL$ Decided to sell one lot to get some premium and lower the cost price of the call option that I bought at 35 previously, still holding onto 100 shares as well
Tesla🚗 Under Investigation👮: Will It Drop to $350 With More Trouble Ahead?
Tesla( $Tesla Motors(TSLA)$ ) Faces New Challenges Tesla is under scrutiny as the National Highway Traffic Safety Administration (NHTSA) investigates 2.6 million of its vehicles. This adds to concerns raised by Bank of America analyst John Murphy, who downgraded Tesla to Neutral, stating that most of its upside potential has already been realized. With Tesla’s shares hovering near $400, investors are left wondering: Is this the time to hold, sell, or buy the dip? 1. Key Concerns Impacting Tesla Downgrade from Bank of America John Murphy’s Statement: Tesla’s recent 60% rally, largely fueled by optimism post-Trump’s election, may have limited room for further growth. Neutral Rating: Murphy believes Tesla’s valuation is stretched, given the challenge
In my Mon, 06 Jan 2025 post, I have termed this week as Jobs Report week because of the 4 jobs reports that will be published one after another from Tuesday onwards. Yesterday, Tue, 07 Jan 2025 saw the first of four (US Jobs opening & Labour turnover surveys - JOLTs) released. And Wall Street decided to sell off stocks and bonds Tuesday after better-than-expected economic data fanned fears that inflation could remain stubbornly high in 2025. When 4pm came around: (see above) DJIA : -0.42% (-178.20 to 42,528.36). S&P 500 : -1.11% (-66.35 to 5,909.03). Nasdaq : -1.89% (-375.30 to 19,489.68). On Tuesday, traders ramped up bets that the Fed would slow its interest rate cut-plans in the coming months, if not hold off on cuts through year’s end. Sectors Performances. As a result of the s
Navigating Market Waves: Economic Data Releases and Their Impact on January 8, 2025
As we delve into the heart of January 2025, the stock market is poised for potential turbulence due to several key economic data releases and events scheduled for today. Here's a comprehensive look at what's on the economic calendar and how these might steer the market's direction. Today's Economic Data Releases: ADP Private Payrolls, Forecast: 130,000 (Previous: 146,000) Impact: This report from Automatic Data Processing Inc. provides an early signal on private sector employment. A higher-than-expected figure might strengthen the dollar, reflecting a robust economy. However, it could also raise concerns about potential rate hikes by the Federal Reserve, putting pressure on stock indices. For instance, if the number exceeds expectations significantly, we might see a repeat of last month's
🪙Treasury Yields Weigh on Market📈: How Many Rate Cuts in 2025?
Rising Treasury Yields Shake Markets U.S. Treasury yields continue to climb, with the 30-year yield rising 3.8 basis points to 4.855%, briefly touching its highest level since November 2023 at 4.861%. Robust ISM data adds to concerns, decreasing the likelihood of rate cuts in 2025. As Friday’s non-farm payroll data looms, investors are left to ponder: Is the market overreacting to ISM data? Should we buy U.S. Treasuries now? Will Treasury prices fill the gap at $85? 1. Key Factors Impacting Markets Treasury Yields at Historic Highs 30-Year Yield Surge: Climbing to 4.861%, reflecting strong economic data. ISM Data Impact: A two-year high in ISM data suggests resilience in the economy, reducing rate cut expectations. Goldman Sachs Prediction No Rate Cuts in 2025: Goldman Sachs analysts belie